News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
ADMA Biologics (ADMA) Q4 2025 Earnings Transcript
↗
Today 0:37 EST
Via
The Motley Fool
Tickers
ADMA
Exposures
Product Safety
Is Regeneron Pharmaceuticals Stock Underperforming the Nasdaq?
Today 0:19 EST
Via
Barchart.com
Topics
Stocks
Exposures
Product Safety
US Equities
Aardvark Therapeutics Becomes Next Pharma Player To Quit Prader-Willi Syndrome Drug Development Efforts
↗
February 27, 2026
Via
Stocktwits
Tickers
AARD
ACAD
SLNO
Exposures
Product Safety
Vesica Health Receives FDA Breakthrough Device Designation for AssureMDx
February 26, 2026
Via
PRLog
Exposures
Product Safety
uniQure N.V. (QURE) Investors: April 13, 2026, Deadline in Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP
February 27, 2026
Via
NewMediaWire
Topics
Fraud
Lawsuit
Tickers
DOCS
QURE
Exposures
Financial
Legal
Product Safety
uniQure N.V. (QURE) Investors: April 13, 2026, Deadline in Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP
February 27, 2026
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Tickers
DOCS
QURE
Exposures
Financial
Legal
Product Safety
The Lilly Era: How Eli Lilly Transformed into a Trillion-Dollar Healthcare Titan
February 27, 2026
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Tickers
LLY
NVO
PFE
RHHBY
XLV
Exposures
Artificial Intelligence
Product Safety
OrthoPediatrics (KIDS) Q4 2025 Earnings Transcript
↗
February 27, 2026
Via
The Motley Fool
Tickers
KIDS
Exposures
Product Safety
The Great Pivot: Inside Novavax’s 2026 Turnaround and the Road to Combination Vaccines
February 27, 2026
Via
Finterra
Topics
Economy
Tickers
MRNA
NVAX
PFE
SNY
Exposures
COVID-19
Product Safety
Supply Chain
Inside the Smucker Surge: A Deep Dive into the Hostess Integration and the $1 Billion Uncrustables Engine
February 27, 2026
Via
Finterra
Topics
Earnings
Economy
World Trade
Tickers
BAC
GIS
GS
JPM
KHC
NSRGY
Exposures
COVID-19
Financial
Interest Rates
NRx Builds Momentum From FDA Progress To Strategic Expansion
February 27, 2026
Via
NewMediaWire
Tickers
NRXP
Exposures
Product Safety
NRx Builds Momentum From FDA Progress To Strategic Expansion
February 27, 2026
Via
TheNewswire.com
Tickers
NRXP
Exposures
Product Safety
Neurogene Stock Soars On FDA Breakthrough Tag For Rett Gene Therapy
↗
February 27, 2026
Via
Benzinga
Exposures
Product Safety
Why Did NGNE Stock Surge 25% In Pre-Market Today?
↗
February 27, 2026
Via
Stocktwits
Tickers
BBC
IWC
KOMP
NGNE
SBIO
Exposures
Product Safety
Kaplan Fox Reminds Corcept Therapeutics, Inc. (CORT) Investors of a Securities Class Action Deadline on April 21, 2026
February 27, 2026
Via
NewMediaWire
Topics
Lawsuit
Tickers
CORT
Exposures
Financial
Legal
Product Safety
Kaplan Fox Reminds Corcept Therapeutics, Inc. (CORT) Investors of a Securities Class Action Deadline on April 21, 2026
February 27, 2026
Via
TheNewswire.com
Topics
Lawsuit
Tickers
CORT
Exposures
Financial
Legal
Product Safety
Down 70% Over the Past Year, Can Hims & Hers Health Stock Bounce Back?
↗
February 27, 2026
Via
The Motley Fool
Topics
Intellectual Property
Lawsuit
Tickers
HIMS
Exposures
Financial
Intellectual Property
Legal
QURE Or RGNX: Which Gene Therapy Was FDA Chief Really Warning About In Rare Disease Remarks?
↗
February 27, 2026
Via
Stocktwits
Tickers
QURE
RGNX
RY
TSX:RY
Exposures
Product Safety
Castle Biosciences (CSTL) Earnings Transcript
↗
February 26, 2026
Via
The Motley Fool
Tickers
CSTL
Exposures
Product Safety
Lantheus (LNTH) Q4 2025 Earnings Call Transcript
↗
February 26, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
LNTH
Exposures
Financial
Product Safety
Intellia (NTLA) Q4 2025 Earnings Call Transcript
↗
February 26, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
NTLA
Exposures
Financial
Product Safety
Boston Scientific Halts Use Of Select Stent Delivery Devices After Patient Deaths
↗
February 26, 2026
Via
Benzinga
Topics
Death
Exposures
Death
Product Safety
Merck's Two-Drug HIV Regimen Challenges Industry Standards Following Positive Phase 3 Results
February 26, 2026
Via
MarketMinute
Topics
Intellectual Property
Tickers
ARM
GILD
GSK
MRK
Exposures
Intellectual Property
Product Safety
Custom vs. Standard LASIK in Portland, Oregon: New Resource from Tersigni Vision Helps Patients Understand Key Differences
February 26, 2026
Via
Press Advantage
Exposures
Product Safety
FDA Commissioner Refers To Rare Disease Drug With Associated Morbidity: Analysts Are Divided If Makary Meant Regenxbio Or Uniqure’s Experimental Therapy
↗
February 26, 2026
Via
Stocktwits
Tickers
QURE
RGNX
Exposures
Product Safety
Uniqure Plummets As FDA's Marty Makary Disparages Rejected Rare Disease Drug
↗
February 26, 2026
Via
Investor's Business Daily
Exposures
Product Safety
Pfizer Secures Full FDA Approval for BRAFTOVI in First-Line Colorectal Cancer, Bolstering Oncology Growth Strategy
February 26, 2026
Via
MarketMinute
Topics
Economy
Intellectual Property
Tickers
AZN
BMY
LLY
MRK
NVS
PFE
Exposures
COVID-19
Intellectual Property
Interest Rates
Corcept Therapeutics (NASDAQ: CORT) Investors Who Have Suffered Losses - Contact Kaplan Fox before April 21, 2026 Lead Plaintiff Deadline
February 26, 2026
Via
TheNewswire.com
Topics
Lawsuit
Tickers
CORT
Exposures
Financial
Legal
Product Safety
Corcept Therapeutics (NASDAQ: CORT) Investors Who Have Suffered Losses - Contact Kaplan Fox before April 21, 2026 Lead Plaintiff Deadline
February 26, 2026
Via
NewMediaWire
Topics
Lawsuit
Tickers
CORT
Exposures
Financial
Legal
Product Safety
Hims & Hers at the Crossroads: Navigating the ‘Regulatory Winter’ of 2026
February 26, 2026
Via
Finterra
Topics
Economy
Initial Public Offering
Intellectual Property
Tickers
AMZN
HIMS
LLY
NVO
Exposures
Financial
Intellectual Property
Interest Rates
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
